TickerTain — Make Analysis Fun Again

▶ 0:16 · $GSK · Emma Walmsley - CEO of GSK | Podcast | In Good Company | Norges Bank Investment Management

now playing · $GSK

Norges Bank owns 1.7% of GSK worth $1.3B

The Norwegian Sovereign Wealth Fund holds a 1.7% stake in GSK valued at $1.3 billion, reflecting confidence in the pharma giant's pipeline and strategy.

$GSK···bullish· highemma walmsley

GSK targets 14 blockbuster launches this decade with AI-driven R&D overhaul

GSK expects 14 medicines and vaccines each with >£2B sales potential this decade, powered by doubled R&D spend, ADC and oligonucleotide platforms, and AI across the discovery valu…

$MSFT···bullish· mediumemma walmsley

GSK CEO leverages Microsoft board seat to import AI into pharma R&D

Emma Walmsley's six-year tenure on Microsoft's board provides GSK direct exposure to cutting-edge AI and cloud technology, which she is applying across GSK's R&D value chain from…

←